CD99 and Ewing sarcoma: Previous results in Ewing’s sarcoma cells, with a CD99 agonist antibody, demonstrated the ability of CD99 to control cell cytoskeleton remodeling and formed adherent junctions and focal adhesions [43], further corroborating the present findings.